1. Hain M, Bawnik Y, Warman M, Halperin D, Leiba H. Neonatal dacryocele with endonasal cyst: revisiting the management. Am J Otolaryngol. 2010 Jan 8.

  2. Bai W, Shao C, Sun W, Ha PK, Califano JA, Cao Z. Conservative management of transnasal intracranial injury. Am J Otolaryngol. 2010 Jan 6.

  3. Saunders J, Murray M, Alleman A. Biofilms in chronic suppurative otitis media and cholesteatoma: scanning electron microscopy findings. Am J Otolaryngol. 2009 Dec 23.

  1. Olansky L, Kennedy L. Finger-Stick Glucose Monitoring: Issues of accuracy and specificity. Diabetes Care. 2010 Apr;33(4):948-9.

  2. The TRIAD Study Group. Health Systems, Patients Factors, and Quality of Care for Diabetes: A synthesis of findings from the TRIAD Study. Diabetes Care. 2010 Apr;33(4):940-947.

  3. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL. Postoperative Mortality in Cancer Patients With Preexisting Diabetes: Systematic review and meta-analysis. Diabetes Care. 2010 Apr;33(4):931-9.

  1. Eur Heart J. 2010 Mar;31(6):629-30.
    The fingertip test which could save millions.

  2. Eur Heart J. 2010 Mar;31(6):630-2.
    Trials and tribulations.

  3. Eur Heart J. 2010 Mar 23. [Epub ahead of print]
    rugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation. Nault I, Miyazaki S, Forclaz A, Wright M, Jadidi A, Jaïs P, Hocini M,Haïssaguerre M. Hôpital Cardiologique Haut-Lévêque, Avenue de Magellan, 33 604, Bordeaux-Pessac cedex, Université Victor Segalen, France. Treatment strategy for atrial fibrillation (AF) is a controversial matter. Catheter ablation is increasingly being used to treat patients with AF, and recent studies have reported success rates >80% for paroxysmal AF and >70% for persistent AF. The purpose of this work is to review the evidence supporting catheter ablation and compare it with pharmacological treatment in the management of AF.

  1. Macones GA, Cahill AG, Stamilio DM, Odibo A. Abdominal sacrocolpopexy and urinary incontinence: Elser et al. Am J Obstet Gynecol. 2010 Apr;202(4):403-404.

  2. Pozharny Y, Lambertini L, Ma Y, Ferrara L, Litton CG, Diplas A, Jacobs AR, J, Stone JL, Wetmur J, Lee MJ. Genomic loss of imprinting in Chen first-trimester human placenta. Am J Obstet Gynecol. 2010 Apr;202(4):391.e1-391.e8.

  3. Lee J, Park JS, Norwitz ER, Kim BJ, Park CW, Jun JK, Syn HC. Identification and characterization of proteins in amniotic fluid that are differentially expressed before and after antenatal corticosteroid administration. Am J Obstet Gynecol. 2010 Apr;202(4):388.e1-388.e10.

  1. Pullatt RC, Silverman DI, Heller GV. Are long-term outcomes of medium- to high-risk patients undergoing vascular surgery affected by the ischemia evaluation strategy? J Am Coll Cardiol. 2010 Mar 30;55(13):1397-8. PubMed PMID: 20338505.

  2. Jabs A, Münzel T. Drug-eluting stent-induced vascular dysfunction common and missing links. J Am Coll Cardiol. 2010 Mar 30;55(13):1399. PubMed PMID: 20338508.

  3. Yasuda S, Shiroto T, Shimokawa H. Reply. J Am Coll Cardiol. 2010 Mar 30;55(13):1399-400. PubMed PMID: 20338507.

Research & Development

Research & Development


Our product development team continues its strong research orientation in formulation development to transform BPL into a truly international one.

 Read More

Manufacturing Facilities

Manufacturing Facilities


Beximco Pharmaceuticals Ltd. (Beximco Pharma) is a leading manufacturer of medicines and active pharmaceutical ingredients (APIs) based in Bangladesh.

 Read More

Corporate Responsibility

Corporate Social Responsibility


CSR initiatives are an integral part of our strategic commitment, and we are always guided by strong ethical values to operate responsibly within broader social and economic context.

 Read More

Health & Wellness

Health & Wellness


Life's all about staying healthy and enjoying the good things in life! However, illness is inevitable at all stages of life. In this area learn about the common health problems.

 Read More

Our Product

  • All
  • Allergic Disorders
  • Analgesics & Antipyretic
  • Anti–infectives
  • Cardiovascular
  • Central Nervous System
  • Cough & Cold
  • Endocrine & Diabetes
  • Eye Care
  • Gastrointestinal
  • Hormones & Steroid
  • Intravenous Fluids
  • Muscloskeletal
  • Oncology
  • Other Products
  • Respiratory
  • Skin Care
  • Vitamins & Minerals Supplement
load more hold SHIFT key to load all

Global Footprint

Beximco Pharma has so far exported medicines to more than 40 countries around the world.

 Read More

Contract Manufacturing Opportunities

Rising cost of healthcare and medicines has become a global concern, and in order to reduce cost across the value chain, pharmaceutical companies from developed markets.

 Read More

Our People

We believe, our dedicated and highly skilled people – their collective resolve to excel- have always guided us towards newer achievements and set a course for the bright future.

 Read More

Investor Relations

This section of our website contains essential information on Beximco Pharmaceuticals Ltd. You can view and download our financial reports and keep up to-date with the latest news and company information.

 Read More


  • invima
  • Asaia most promising brand



  • FDA Export


  • TGA
  • AGES
  • GCC
  • TFDA
  • Health Canada